Skip to main content

Top Left Menu

  • Careers
  • Media
  • Investors
  • Library

What are you looking for?

Home

You are here

Galderma Global

Choose another location

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Hong Kong/Macau SAR, China
  • India
  • Italy
  • Japan
  • Kingdom of Saudi Arabia
  • Korea
  • Mainland China
  • Mexico
  • Middle East
  • Netherlands
  • Nordic
  • Norway
  • Poland
  • Portugal
  • Russia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, China
  • Thailand
  • United Kingdom
  • United States
  • Venezuela

Top menu

  • Contact us
  • Search

Main navigation

  • About us
    • At a glance
    • Our purpose
    • Our strategy
    • Our sub-categories
    • Global presence
    • Executive Committee
    • Governance
    • Annual Report 2025
  • Skin Stories
    • Galderma skin stories
    • Skin Science
    • Beauty x Medicine
    • Galderma Insights
    • Podcasts
  • Innovation
    • Bringing innovation to life
    • Partnerships
    • Manufacturing
    • Early Access
  • Our brands
  • Sustainability
    • For our employees
    • For patients and consumers
    • For healthcare professionals and customers
    • Governance oversight
    • Funding request for education and support activities
    • Our ESG Index
  • Media
  • Careers
  • Investors
  • Library
You searched for: «sculptra»
Results 106 - 110 of 111
Page 22 of 23
  1. Media
  2. Newsroom

Powered by Peptides: Galderma introduces Cetaphil Healthy Renew, a retinol alternative skincare range

The Healthy Renew collection helps defend against visible signs of aging while being gentle enough for daily use on sensitive skin.

 

ANNUAL REPORT 2024

  1. Media
  2. Newsroom

Galderma demonstrates Injectable Aesthetics leadership in medication-driven weight loss with new research and first international consensus-based guidelines

  • New research shows that loose or sagging skin on the face and neck is most often noted after medication-driven weight loss, with facial changes typically observed 3-6 months following treatment (in 45% of respondents), and sometimes as early as 1-2 months (28%)[1]
  • In addition, more than 60% of those patients experiencing medication-driven weight
  1. Media
  2. Newsroom

Galderma showcases its continued commitment to innovation in dermatology with new data to be presented at 2022 EADV congress

  • Galderma, the pure-play dermatology category leader with a 40+ year heritage in dermatology, will present one oral, six symposia and four hub sessions demonstrating its scientific expertise and ongoing commitment to advancing dermatology
  • 18 scientific and clinical posters will unveil new data on skin disease awareness and scientific innovation in prurig
  1. Media
  2. Newsroom

AAD 2023: Late-Breaking Phase III results demonstrate nemolizumab’s significant impact on prurigo nodularis

Extensive updates from broad and innovative portfolio also to be presented

 

Results 106 - 110 of 111
Page 22 of 23

Pagination

  • Previous page Previous Page
  • Next page Next Page
  1. Home
  2. Search results

STAY CONNECTED

Follow us on Social Media for current news and patients stories

Instagram LinkedIn Icon Twitter Icon
© Galderma 2026

Footer menu 2

  • Terms of use
  • Cookie Policy
  • Privacy
  • Sitemap

Confirm navigation

You are about to leave the Galderma global site. Are you sure you want to leave this page?

Yes, thanks Go back